Correlation Between Teva Pharmaceutical and Dr Reddys

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Teva Pharmaceutical and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharmaceutical and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharmaceutical Industries and Dr Reddys Laboratories, you can compare the effects of market volatilities on Teva Pharmaceutical and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharmaceutical with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharmaceutical and Dr Reddys.

Diversification Opportunities for Teva Pharmaceutical and Dr Reddys

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Teva and RDDA is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharmaceutical Industries and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Teva Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharmaceutical Industries are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Teva Pharmaceutical i.e., Teva Pharmaceutical and Dr Reddys go up and down completely randomly.

Pair Corralation between Teva Pharmaceutical and Dr Reddys

Assuming the 90 days horizon Teva Pharmaceutical Industries is expected to generate 2.35 times more return on investment than Dr Reddys. However, Teva Pharmaceutical is 2.35 times more volatile than Dr Reddys Laboratories. It trades about 0.14 of its potential returns per unit of risk. Dr Reddys Laboratories is currently generating about 0.04 per unit of risk. If you would invest  1,565  in Teva Pharmaceutical Industries on September 23, 2024 and sell it today you would earn a total of  555.00  from holding Teva Pharmaceutical Industries or generate 35.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Teva Pharmaceutical Industries  vs.  Dr Reddys Laboratories

 Performance 
       Timeline  
Teva Pharmaceutical 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharmaceutical Industries are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Teva Pharmaceutical reported solid returns over the last few months and may actually be approaching a breakup point.
Dr Reddys Laboratories 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dr Reddys Laboratories are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental indicators, Dr Reddys is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Teva Pharmaceutical and Dr Reddys Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Teva Pharmaceutical and Dr Reddys

The main advantage of trading using opposite Teva Pharmaceutical and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharmaceutical position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.
The idea behind Teva Pharmaceutical Industries and Dr Reddys Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Technical Analysis
Check basic technical indicators and analysis based on most latest market data